Metagenomic analysis of human feces reveals gut microbiome role in colorectal cancer
Frontiers in Cellular and Infection Microbiology · 15.06.2026 · 16
DOI: 10.3389/fcimb.2026.1828012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 15.06.2026. Verfasst von Zehui Gu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Third Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Feces, Metagenomics, Gastrointestinal Microbiome. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
This study aimed to identify the microbiota and specific genes that are closely associated with colorectal cancer (CRC) through metagenomic sequencing and integrative multi-omics analysis.
Methods
Fecal samples were collected from 11 healthy volunteers and 20 patients with CRC. Genomic DNA was extracted for metagenomic analysis and high-throughput sequencing. Compositional differences and correlations of the gut microbiome were compared based on species and functional diversity.
Results
The overall species composition included 1,980 species, with 1,707 species identified in the CRC group and 1,525 in the healthy control group. Alpha diversity was significantly lower in the CRC group than in the healthy control group ( p = 0.014). Beta diversity analysis revealed significant differences between the two groups (stress = 0.1308, p = 0.021). Based on LEfSe analysis, Shigella , Porphyromonas , Proteus , Bacteroides , Alistipes , Fusobacterium , and Escherichia were more abundant in patients with CRC, whereas Eubacterium , Clostridium , Dialister , Faecalibacterium , Blautia , Coprococcus , Dorea , Subdoligranulum , Megamonas , Roseburia , and Prevotella were significantly more abundant in the healthy control group ( p < 0.05).
Conclusion
A multidimensional microbial diagnostic model, incorporating Shigella, Porphyromonas, Proteus, Bacteroides, Fusobacterium, Escherichia, Eubacterium, Clostridium, Dialister, Faecalibacterium, Blautia, Coprococcus, Dorea, Subdoligranulum, Megamonas, Roseburia, and Prevotella, suggests the potential to enhance early CRC screening performance. Furthermore, LptA, tnaA, envC, and argB may represent promising candidates for novel therapeutic targets, warranting further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, The Third Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China.
- Department of General Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China.
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China.
- Department of Precision Medicine, The Third Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China.
- Department of Oncology, The Third Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China.
Zitieren
APA
Gu, Z., Tan, Q., Mao, D., Zhang, Y., Wang, Y., He, D., & Chen, S. (2026). Metagenomic analysis of human feces reveals gut microbiome role in colorectal cancer. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1828012
Vancouver
Gu Z, Tan Q, Mao D, Zhang Y, Wang Y, He D, et al. Metagenomic analysis of human feces reveals gut microbiome role in colorectal cancer. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1828012
BibTeX
@article{Gu2026,
author = {Gu, Zehui and Tan, Qi and Mao, Dong and Zhang, Yun and Wang, Yadi and He, Dongning and Chen, Suxian},
title = {Metagenomic analysis of human feces reveals gut microbiome role in colorectal cancer},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1828012}
}
EUVIMED